Atrial Fibrillation: A Novel Risk Factor for No-Reflow Following Primary Percutaneous Coronary Intervention

Basit Öğe Kaydı
dc.authoridCinier, Goksel/0000-0001-5064-1816
dc.authoridTATLISU, Mustafa A/0000-0003-1058-7194
dc.authoridKeskin, Muhammed/0000-0002-4938-0097
dc.authoridYILDIRIM, Ersin/0000-0002-3311-1095
dc.authoridkaya, adnan/0000-0002-9225-8353
dc.authorwosidCinier, Goksel/Y-1715-2019
dc.authorwosidTATLISU, Mustafa A/H-5340-2018
dc.authorwosidKeskin, Muhammed/W-8229-2018
dc.contributor.authorKaya, Adnan
dc.contributor.authorKeskin, Muhammed
dc.contributor.authorTatlisu, Mustafa Adem
dc.contributor.authorUzman, Osman
dc.contributor.authorBorklu, Edibe
dc.contributor.authorCinier, Goksel
dc.contributor.authorKayapinar, Osman
dc.date.accessioned2021-12-01T18:49:54Z
dc.date.available2021-12-01T18:49:54Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractThere is a lack of evidence regarding the association of atrial fibrillation (AF) and no-reflow (NR) phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (pPCI). A total of 2452 patients with STEMI who underwent pPCI were retrospectively investigated. After exclusions, 370 (14.6%) patients were in the AF group and 2095 (85.4%) were in the No-AF group. Patients with a thrombolysis in myocardial infarction flow rate <3 were defined as having NR. Patients in the AF group were older and had higher 3-vessel disease rates (24.1% vs 18.9%; P = .021) and lower left ventricular ejection fraction (45.4 [11.7] vs 48.7 [10.5%]; P < .001). No-reflow rates were higher in the AF group than in the No-AF group (29.1% vs 11.8%; P < .001). According to multivariable analysis, AF (odds ratio: 1.81, 95% confidence interval: 1.63-2.04, P < .001), age, Killip class, anterior myocardial infarction, diabetes mellitus, chronic kidney disease, stent length, and smoking were independent predictors of NR following pPCI. Atrial fibrillation is a quite common arrhythmia in patients with STEMI. Atrial fibrillation was found to be an independent predictor of NR in the current study. This effect of AF on coronary flow rate might be considered as an important risk factor in STEMI.en_US
dc.identifier.doi10.1177/0003319719840589
dc.identifier.endpage182en_US
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85064251241en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage175en_US
dc.identifier.urihttps://doi.org/10.1177/0003319719840589
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10796
dc.identifier.volume71en_US
dc.identifier.wosWOS:000504503300010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofAngiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectatrial fibrillationen_US
dc.subjectno-reflowen_US
dc.subjectprimary percutaneous coronary interventionen_US
dc.subjectAcute Myocardial-Infarctionen_US
dc.subjectSt-Segment Elevationen_US
dc.subjectC-Reactive Proteinen_US
dc.subjectArtery-Diseaseen_US
dc.subjectStroke Preventionen_US
dc.subjectHeart-Diseaseen_US
dc.subjectShort-Termen_US
dc.subjectOutcomesen_US
dc.subjectReperfusionen_US
dc.subjectIschemiaen_US
dc.titleAtrial Fibrillation: A Novel Risk Factor for No-Reflow Following Primary Percutaneous Coronary Interventionen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
10796.pdf
Boyut:
210.51 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu